This is HUGE for QNTA shareholders! May 22, 2021, the registrant had 176,458,527 shares of Common Stock outstanding.
You got it cj - it's a SPECTACULAR and almost unheard of LOW and LOW FLOAT share count for any OTC company !!
And this is the final POST MERGER NUMBER - which involved a large share issuance of approx 70 million, etc.
ALL NEW MGT from the MedoLife Rx merger (now fully completed) and they made it patently clear in the newly filed SEC 10-Q of today, "WE ARE CLEANING UP LEGACY PROBLEMS left by prior mgt team" etc.
That share count could DOUBLE IN THE NEXT YR - and STILL = a mega low floater and low share count for any growth company :)
Their A/S (available share count) is set at a paltry 500 million = they do NOT plan on massive dilution going forward !
Just a little GET THE TRUTH OUT THERE and this AM selling by the amateurs can see a fully reversal and close this FLAT to even green - when people grasp the magnitude of this now FULLY COMPLETED MERGER and what is about to happen here -
FDA IND in the pipe and a liquid gold scorpion venom lead product now that can be SOLD LEGALLY outside the USA and it goes for $40 MILLION a gallon and this newly created company QNTA post merger can make 5 GALLONS A YR or $200 mil worth of literal liquid gold -
Sell it into Asia and Latin America and on and on and on - the FDA IND is a cherry on top and sends this to a FIVE BAGGER in two days of trading on one PR with words, "QNTA IS GRANTED FDA IND" blah blah :)